Agency
Virginia Department of Health
 
Board
State Board of Health
 
chapter
Regulations for the Immunization of School Children [12 VAC 5 ‑ 110]
Previous Comment     Next Comment     Back to List of Comments
10/11/21  2:09 pm
Commenter: Anonymous

NO COVID-19 Vaccine Mandates for K-12 STUDENTS or school employees/staff
 

Please provide the public an isolated virus sample of SARS-CoV-2. No one, nationally or internationally, has been able to provide an isolated SARS-CoV-2 virus sample. Any mandate of a COVID-19 vaccine is unnecessary if there is no isolated virus. When a Level 4 lab orders an Ebola virus, they are provided an isolated sample of the virus. Labs cannot order a SARS-CoV-2 virus because it doesn't exist. The vaccine isn't FDA approved. For children the vaccine isn't approved. Mandates for experimental medical therapies are neither permissible nor advisable. The Pfizer and Moderna and AstraZeneca applications properly identify their new agents as “investigational,” which is normal at this very early stage of development. The pharmaceutical companies have applied for investigational use status.  Vaccine safety requires proper animal trials and peer-reviewed data, neither of which has occurred during operation warp speed. Prior coronavirus (and other respiratory) vaccines have failed due to the scientific phenomena known as pathogenic priming that makes the vaccine recipient more likely to suffer a sudden fatal outcome due to massive cytokine storm when exposed to the wild virus. In addition to pathogenic priming there are three other potential safety issues that are being minimized.  Countries where HCQ is widely available, which are typically third world countries that have malaria or citizens who travel to malaria-endemic regions, have1-10% of the death rates of first world nations where HCQ is severely restricted. HCQ availability correlates with COVID-19 death rates. Everywhere HCQ is used, the death rates are much lower. COVID-19 Survival Rates by age group are: 0-19: 99.997%; 20-49: 99.98%; 50-69: 99.5%; 70+: 94.6%.  The survival rate of a bee sting is (for all age groups) 99.97%. No vaccine based on messenger RNA has ever been approved for any disease, or even entered final-stage trials until now, so there’s no peer-reviewed published human data to compare how mRNA stacks up against older technologies.  (https://www.bloomberg.com/features/2020-moderna-biontech-COVID-shot/ ). Pathogenic priming includesthe deleterious effect of antibody-dependent enhancement (ADE) whereby a vaccine or reinfection could result in a more severe or lethal disease,should the person become infected with SARS-CoV-2in the wild. (https://www.sciencemag.org/news/2019/04/dengue-vaccine-fiasco-leads-criminal-charges-researcher-philippines)
Most other previous vaccines have performed and published results on animal studies prior to givingto humans. This is critical because deadly effects are often not seen until this step. Vaccines that have been given to humans prior to animal trials have frequently resulted in deaths that caused the governments to yank the vaccines. Most scientists believe that human death is inevitable if there are no prior peer-reviewed animal studies. We learn about these studies only from the company itself.  (https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-data-preclinical-studies-mrna ) There is absolutely No Proof the Vaccine Stops Transmission of the Virus. These agents are being distributed under an EUA (emergency use authorization) which determines how future harm to patients will be compensated. (https://www.fda.gov/media/144245/download?utm_campaign=The%20DC%20Today&utm_medium=email&_hsmi=102466647&_hsenc=p2ANqtz--L3Cb8fl6aCL4ZBDWT3lZC_zZIxF7sEiXXY- )

CommentID: 107254